Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Clark Gamblin

Showing results (1-10 of 226) with videos related to

Pageof 23
Sort By:
Surgical Oncology Clinics of North America|September 2, 2019
Hepatobiliary Malignancies: The Changing LandscapeT Clark Gamblin
Surgical Oncology Clinics of North America|September 2, 2019
Molecular Characteristics of Biliary Tract and Primary Liver TumorsSusan Tsai, T Clark Gamblin
Surgical Oncology Clinics of North America|February 25, 2014
Palliation: treating patients with inoperable biliary tract and primary liver tumorsAlbert Amini, T Clark Gamblin
Journal of Surgical Education|June 9, 2012
Measuring the surgical academic output of an institution: the "institutional" H-indexKiran K Turaga, T Clark Gamblin
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2005
Downstaging hepatocellular carcinoma prior to liver transplantationT Clark Gamblin, David A Geller
Surgical Oncology Clinics of North America|December 3, 2014
Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasisJohn T Miura, T Clark Gamblin
Current Surgery|August 12, 2005
Flail chest caused by penetrating trauma: a case reportT Clark Gamblin, Martin L Dalton
The Surgical Clinics of North America|July 20, 2010
Hepatic resection nomenclature and techniquesScott A Celinski, T Clark Gamblin
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 7, 2015
Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expressionSelvi Kunnimalaiyaan, T Clark Gamblin, Muthusamy Kunnimalaiyaan
Hepatology (Baltimore, Md.)|April 27, 2016
Cholangiocarcinoma risk factors and the potential role of aspirinFabio Bagante, T Clark Gamblin, Timothy M Pawlik
Pageof 23

Showing results (1-10 of 226) with videos related to

Sort By:
Pageof 23
Surgical Oncology Clinics of North America|September 2, 2019
Hepatobiliary Malignancies: The Changing LandscapeT Clark Gamblin
Surgical Oncology Clinics of North America|September 2, 2019
Molecular Characteristics of Biliary Tract and Primary Liver TumorsSusan Tsai, T Clark Gamblin
Surgical Oncology Clinics of North America|February 25, 2014
Palliation: treating patients with inoperable biliary tract and primary liver tumorsAlbert Amini, T Clark Gamblin
Journal of Surgical Education|June 9, 2012
Measuring the surgical academic output of an institution: the "institutional" H-indexKiran K Turaga, T Clark Gamblin
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2005
Downstaging hepatocellular carcinoma prior to liver transplantationT Clark Gamblin, David A Geller
Surgical Oncology Clinics of North America|December 3, 2014
Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasisJohn T Miura, T Clark Gamblin
Current Surgery|August 12, 2005
Flail chest caused by penetrating trauma: a case reportT Clark Gamblin, Martin L Dalton
The Surgical Clinics of North America|July 20, 2010
Hepatic resection nomenclature and techniquesScott A Celinski, T Clark Gamblin
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 7, 2015
Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expressionSelvi Kunnimalaiyaan, T Clark Gamblin, Muthusamy Kunnimalaiyaan
Hepatology (Baltimore, Md.)|April 27, 2016
Cholangiocarcinoma risk factors and the potential role of aspirinFabio Bagante, T Clark Gamblin, Timothy M Pawlik
Pageof 23